Evogene EVGN Stock
Evogene Price Chart
Evogene EVGN Financial and Trading Overview
| Evogene stock price | 1.26 USD |
| Previous Close | 1.25 USD |
| Open | 1.25 USD |
| Bid | 1.2 USD x 100 |
| Ask | 1.25 USD x 100 |
| Day's Range | 1.22 - 1.28 USD |
| 52 Week Range | 0.95 - 4.29 USD |
| Volume | 16.24K USD |
| Avg. Volume | 1.85M USD |
| Market Cap | 11.1M USD |
| Beta (5Y Monthly) | 1.415 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.97 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.5 USD |
EVGN Valuation Measures
| Enterprise Value | 16.99M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.35549134 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.6413836 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.511 |
| Enterprise Value/EBITDA | -0.803 |
Trading Information
Evogene Stock Price History
| Beta (5Y Monthly) | 1.415 |
| 52-Week Change | -70.43% |
| S&P500 52-Week Change | 18.63% |
| 52 Week High | 4.29 USD |
| 52 Week Low | 0.95 USD |
| 50-Day Moving Average | 1.32 USD |
| 200-Day Moving Average | 1.46 USD |
EVGN Share Statistics
| Avg. Volume (3 month) | 1.85M USD |
| Avg. Daily Volume (10-Days) | 103.44K USD |
| Shares Outstanding | 8.71M |
| Float | 6.61M |
| Short Ratio | 0.82 |
| % Held by Insiders | 0.96% |
| % Held by Institutions | 4.95% |
| Shares Short | 151.73K |
| Short % of Float | 1.73% |
| Short % of Shares Outstanding | 1.73% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -224.81% |
| Operating Margin (ttm) | -168.82% |
| Gross Margin | 41.06% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.10% |
| Return on Equity (ttm) | -91.047% |
Income Statement
| Revenue (ttm) | 6.77M USD |
| Revenue Per Share (ttm) | 1.1 USD |
| Quarterly Revenue Growth (yoy) | -41.69% |
| Gross Profit (ttm) | 2.78M USD |
| EBITDA | -21154000 USD |
| Net Income Avi to Common (ttm) | -15209000 USD |
| Diluted EPS (ttm) | -2.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.85M USD |
| Total Cash Per Share (mrq) | 1.48 USD |
| Total Debt (mrq) | 2.59M USD |
| Total Debt/Equity (mrq) | 20.91 USD |
| Current Ratio (mrq) | 1.058 |
| Book Value Per Share (mrq) | -0.546 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20772000 USD |
| Levered Free Cash Flow (ttm) | -3160250 USD |
Profile of Evogene
| Country | United States |
| State | N/A |
| City | Rehovot |
| Address | 13 Gad Feinstein Street |
| ZIP | 7638517 |
| Phone | 972 8 931 1900 |
| Website | https://www.evogene.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 117 |
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Q&A For Evogene Stock
What is a current EVGN stock price?
Evogene EVGN stock price today per share is 1.26 USD.
How to purchase Evogene stock?
You can buy EVGN shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evogene?
The stock symbol or ticker of Evogene is EVGN.
Which industry does the Evogene company belong to?
The Evogene industry is Biotechnology.
How many shares does Evogene have in circulation?
The max supply of Evogene shares is 8.92M.
What is Evogene Price to Earnings Ratio (PE Ratio)?
Evogene PE Ratio is now.
What was Evogene earnings per share over the trailing 12 months (TTM)?
Evogene EPS is -1.97 USD over the trailing 12 months.
Which sector does the Evogene company belong to?
The Evogene sector is Healthcare.
Evogene EVGN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Global Market Composite NQGM | 2309.83 USD — |
+1.58
|
— — | 2282.44 USD — | 2312.75 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
- {{ link.label }} {{link}}